Literature DB >> 34793202

The X chromosome dosage compensation program during the development of cynomolgus monkeys.

Ikuhiro Okamoto1,2, Tomonori Nakamura1,2,3, Kotaro Sasaki2, Yukihiro Yabuta1,2, Chizuru Iwatani4, Hideaki Tsuchiya4, Shin-Ichiro Nakamura4, Masatsugu Ema1,4, Takuya Yamamoto1,5,6,7, Mitinori Saitou1,2,5.   

Abstract

X chromosome dosage compensation ensures balanced gene dosage between the X chromosome and autosomes and between the sexes, involving divergent mechanisms among mammals. We elucidated a distinct mechanism for X chromosome inactivation (XCI) in cynomolgus monkeys, a model for human development. The trophectoderm and cytotrophoblast acquire XCI around implantation through an active intermediate bearing repressive modifications and compacted structure, whereas the amnion, epiblast, and hypoblast maintain such an intermediate protractedly, attaining XCI by a week after implantation. Males achieve X chromosome up-regulation (XCU) progressively, whereas females show XCU coincidentally with XCI, both establishing the X:autosome dosage compensation by 1 week after implantation. Conversely, primordial germ cells undergo X chromosome reactivation by reversing the XCI pathway early during their development. Our findings establish a foundation for clarifying the dosage compensation mechanisms in primates, including humans.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34793202     DOI: 10.1126/science.abd8887

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  9 in total

1.  Silencing XIST on the future active X: Searching human and bovine preimplantation embryos for the repressor.

Authors:  Melis A Aksit; Bo Yu; Bernard A J Roelen; Barbara R Migeon
Journal:  Eur J Hum Genet       Date:  2022-05-19       Impact factor: 4.246

2.  Ex vivo reconstitution of fetal oocyte development in humans and cynomolgus monkeys.

Authors:  Ken Mizuta; Yoshitaka Katou; Baku Nakakita; Aoi Kishine; Yoshiaki Nosaka; Saki Saito; Chizuru Iwatani; Hideaki Tsuchiya; Ikuo Kawamoto; Masataka Nakaya; Tomoyuki Tsukiyama; Masahiro Nagano; Yoji Kojima; Tomonori Nakamura; Yukihiro Yabuta; Akihito Horie; Masaki Mandai; Hiroshi Ohta; Mitinori Saitou
Journal:  EMBO J       Date:  2022-08-01       Impact factor: 14.012

Review 3.  Gene regulation in time and space during X-chromosome inactivation.

Authors:  Agnese Loda; Samuel Collombet; Edith Heard
Journal:  Nat Rev Mol Cell Biol       Date:  2022-01-10       Impact factor: 113.915

4.  Stem-cell-derived trophoblast organoids model human placental development and susceptibility to emerging pathogens.

Authors:  Rowan M Karvas; Shafqat A Khan; Sonam Verma; Yan Yin; Devesha Kulkarni; Chen Dong; Kyoung-Mi Park; Brian Chew; Eshan Sane; Laura A Fischer; Deepak Kumar; Liang Ma; Adrianus C M Boon; Sabine Dietmann; Indira U Mysorekar; Thorold W Theunissen
Journal:  Cell Stem Cell       Date:  2022-05-05       Impact factor: 25.269

Review 5.  Mechanisms of Choice in X-Chromosome Inactivation.

Authors:  Giulia Furlan; Rafael Galupa
Journal:  Cells       Date:  2022-02-03       Impact factor: 6.600

6.  X Chromosome Inactivation Timing is Not eXACT: Implications for Autism Spectrum Disorders.

Authors:  Janine M LaSalle
Journal:  Front Genet       Date:  2022-03-09       Impact factor: 4.599

7.  Noncanonical imprinting sustains embryonic development and restrains placental overgrowth.

Authors:  Shogo Matoba; Chisayo Kozuka; Azusa Inoue; Kento Miura; Kimiko Inoue; Mami Kumon; Ryoya Hayashi; Tatsuya Ohhata; Atsuo Ogura
Journal:  Genes Dev       Date:  2022-04-28       Impact factor: 12.890

Review 8.  Epigenetic manipulation to improve mouse SCNT embryonic development.

Authors:  Yamei Li; Qiang Sun
Journal:  Front Genet       Date:  2022-08-30       Impact factor: 4.772

Review 9.  Long noncoding RNA XIST: Mechanisms for X chromosome inactivation, roles in sex-biased diseases, and therapeutic opportunities.

Authors:  Jianjian Li; Zhe Ming; Liuyi Yang; Tingxuan Wang; Gaowen Liu; Qing Ma
Journal:  Genes Dis       Date:  2022-04-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.